Business Description
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Business History
Price Overview
Last updated: Jun 27, 2026 10:02am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 5.97
Total Equity: $2.67B
Shares: 66,724,999
Total Debt: $1.48B
Cash: $402.42M
EBITDA: $831.48M
Total Debt: $1.48B
Cash: $402.42M
Revenue: $3.78B
Revenue: $3.78B
Revenue: $3.78B
Total Equity: $2.67B
Tax Rate: 20.1%
Equity: $2.67B
Total Debt: $1.48B
Cash: $402.42M
Current Liabilities: $1.17B
Long-Term Debt: $1.14B
Total Debt: $1.48B
Total Equity: $2.67B
Shares: 66,724,999
Shares: 66,724,999
CapEx: -$270.42M
Shares: 66,724,999
Stock Price: $125.98
Net Income: $392.79M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 6:54pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.3B | $3.5B | $3.6B | $3.8B |
| Cost of Revenue | $2.1B | $2.2B | $2.2B | $2.2B | $2.7B |
| Gross Profit | $1.2B | $1.2B | $1.3B | $1.4B | $1.1B |
| Operating Expenses | $809.3M | $784.6M | $859.4M | $859.0M | $605.0M |
| Operating Income | $347.3M | $379.3M | $404.0M | $496.5M | $512.3M |
| Net Income | $244.1M | $239.3M | $284.5M | $374.5M | $392.8M |
| EBITDA | $586.8M | $609.4M | $663.8M | $777.4M | $831.5M |
| EPS | $3.72 | $3.66 | $4.34 | $5.65 | $5.97 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 6:54pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $122.9M | $141.7M | $223.6M | $223.8M | $402.4M |
| Total Current Assets | $1.4B | $1.4B | $1.5B | $1.5B | $1.9B |
| Total Assets | $4.1B | $4.2B | $4.5B | $4.4B | $5.3B |
| Current Liabilities | $982.5M | $917.2M | $1.3B | $1.1B | $1.2B |
| Long-Term Debt | $907.0M | $1.1B | $681.2M | $688.1M | $1.1B |
| Total Liabilities | $2.2B | $2.1B | $2.1B | $1.9B | $2.5B |
| Total Equity | $2.0B | $2.1B | $2.3B | $2.5B | $2.7B |
| Retained Earnings | $1.8B | $1.9B | $2.1B | $2.4B | $2.6B |
Cash Flow (Annual)
Last updated: Jun 21, 2026 6:54pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $363.4M | $478.6M | $575.2M | $643.4M | $570.0M |
| Capital Expenditure | -$307.9M | -$315.6M | -$318.4M | -$294.2M | -$270.4M |
| Free Cash Flow | $55.5M | $163.0M | $256.8M | $349.2M | $299.6M |
| Acquisitions (net) | -$148.4M | -$4.1M | -$16.6M | $0 | -$55.9M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$78.1M | -$92.1M | -$47.6M | -$68.6M | -$365.0M |
| Net Change in Cash | -$182.0M | $19.8M | $81.4M | $201,000 | $178.1M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 10:02am (just now)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$3.7B $3.7B – $3.7B
|
$4.0B $3.9B – $4.0B
|
$4.2B $4.1B – $4.2B
|
$4.4B $4.4B – $4.4B
|
| EBITDA |
$732.5M $730.5M – $734.5M
|
$791.0M $783.0M – $799.0M
|
$827.8M $821.8M – $831.8M
|
$877.1M $873.4M – $880.8M
|
| Net Income |
$381.1M $379.1M – $383.1M
|
$367.4M $354.9M – $380.0M
|
$402.1M $393.9M – $446.5M
|
$472.1M $448.7M – $495.5M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 6:54pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +2.9% | +5.0% | +2.7% | +5.4% |
| Gross Profit Growth | +0.6% | +8.6% | +7.3% | -17.6% |
| Operating Income Growth | +9.2% | +6.5% | +22.9% | +3.2% |
| Net Income Growth | -2.0% | +18.9% | +31.7% | +4.9% |
| EBITDA Growth | +3.9% | +8.9% | +17.1% | +6.9% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-15 | Gandhi Aditya | A-Award | 2,664.00 | $0.00 | $0 |
| 2026-06-09 | Prieur Marc | S-Sale | 4,553.00 | $115.53 | $526,007 |
| 2026-06-09 | Prieur Marc | S-Sale | 447.00 | $116.08 | $51,887 |
| 2026-06-08 | Gandhi Aditya | 0.00 | $0.00 | $0 | |
| 2026-06-04 | Vinczeller Shiela | S-Sale | 2,957.00 | $112.36 | $332,240 |
| 2026-06-04 | Vinczeller Shiela | S-Sale | 385.00 | $113.52 | $43,706 |
| 2026-06-04 | Vinczeller Shiela | S-Sale | 213.00 | $114.53 | $24,395 |
| 2026-05-26 | Gong Xiangwei | S-Sale | 4,200.00 | $116.13 | $487,765 |
| 2026-05-21 | Tlili Hedi | F-InKind | 688.00 | $116.50 | $80,152 |
| 2026-05-07 | Hudson Irene Elizabeth | M-Exempt | 842.00 | $111.38 | $93,782 |
| 2026-05-07 | Hudson Irene Elizabeth | S-Sale | 422.00 | $123.38 | $52,067 |
| 2026-05-07 | Hudson Irene Elizabeth | S-Sale | 842.00 | $123.45 | $103,946 |
| 2026-05-07 | Hudson Irene Elizabeth | M-Exempt | 842.00 | $111.38 | $93,782 |
| 2026-05-06 | Marey-Semper Isabel | A-Award | 1,326.00 | $0.00 | $0 |
| 2026-05-06 | Kampouri Monnas Giovanna | A-Award | 1,326.00 | $0.00 | $0 |
| 2026-05-06 | Owens B Craig | A-Award | 1,326.00 | $0.00 | $0 |
| 2026-05-06 | Glickman Sarah JS | A-Award | 1,326.00 | $0.00 | $0 |
| 2026-05-06 | FOTIADES GEORGE L | A-Award | 1,326.00 | $0.00 | $0 |
| 2026-05-06 | Trerotola Matthew L. | A-Award | 1,326.00 | $0.00 | $0 |
| 2026-05-06 | Wunderlich Ralf K. | A-Award | 1,326.00 | $0.00 | $0 |
Dividend History (Last 20)
Last updated: Jun 21, 2026 6:54pm (5d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-06 | $0.48 | 2026-04-23 | 2026-05-06 | 2026-05-27 |
| 2026-02-04 | $0.48 | 2026-01-22 | 2026-02-04 | 2026-02-25 |
| 2025-10-23 | $0.48 | 2025-09-08 | 2025-10-23 | 2025-11-13 |
| 2025-07-24 | $0.45 | 2025-07-10 | 2025-07-24 | 2025-08-14 |
| 2025-05-01 | $0.45 | 2025-04-17 | 2025-05-01 | 2025-05-22 |
| 2025-02-05 | $0.45 | 2025-01-23 | 2025-02-05 | 2025-02-26 |
| 2024-10-24 | $0.45 | 2024-10-10 | 2024-10-24 | 2024-11-14 |
| 2024-07-25 | $0.45 | 2024-07-11 | 2024-07-25 | 2024-08-15 |
| 2024-04-24 | $0.41 | 2024-04-11 | 2024-04-25 | 2024-05-16 |
| 2024-01-31 | $0.41 | 2024-01-18 | 2024-02-01 | 2024-02-22 |
| 2023-10-25 | $0.41 | 2023-10-12 | 2023-10-26 | 2023-11-16 |
| 2023-07-26 | $0.41 | 2023-07-13 | 2023-07-27 | 2023-08-17 |
| 2023-05-03 | $0.38 | 2023-04-20 | 2023-05-04 | 2023-05-25 |
| 2023-02-01 | $0.38 | 2023-01-19 | 2023-02-02 | 2023-02-23 |
| 2022-10-25 | $0.38 | 2022-10-13 | 2022-10-26 | 2022-11-16 |
| 2022-07-26 | $0.38 | 2022-07-13 | 2022-07-27 | 2022-08-17 |
| 2022-04-26 | $0.38 | 2022-04-14 | 2022-04-27 | 2022-05-18 |
| 2022-02-02 | $0.38 | 2022-01-20 | 2022-02-03 | 2022-02-23 |
| 2021-10-26 | $0.38 | 2021-10-14 | 2021-10-27 | 2021-11-17 |
| 2021-08-03 | $0.38 | 2021-07-22 | 2021-08-04 | 2021-08-25 |
Narrative Economics
market-narrative step).